全球綜合代謝檢測市場，2025-2029年

全球綜合代謝指標檢測市場預計將從 2024 年到 2029 年成長 58.39 億美元，預測期內複合年成長率為 8.6%。

本報告對綜合代謝指標檢測市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約 25 家公司的供應商分析。

該報告對當前市場格局、最新趨勢和促進因素以及整體市場環境進行了最新分析，而整體市場環境的促進因素包括慢性病發病率的上升、老齡化人口的擴大以及診斷技術和實驗室自動化方面的技術進步。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

該研究指出，即時代謝檢測 (POC) 的興起是未來幾年推動全球綜合代謝檢測市場成長的主要因素之一，而人工智慧 (AI) 在代謝分析中的應用以及家庭和直接面對消費者 (DTC) 代謝檢測的擴展預計將在市場上產生巨大的需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 價格、生命週期、顧客購買籃、採用率和購買標準分析
• 投入與差異化因素的重要性
• 混淆來源
• 促進因素和挑戰的影響

第3章 市場情勢

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場定義
• 市場區隔分析
• 2024年市場規模
• 2024-2029年市場展望

第5章 市場規模表現

• 2019-2023年全球綜合代謝指標檢測市場
• 應用細分市場分析 2019-2023
• 2019-2023年測試段分析
• 2019-2023年最終用戶細分市場分析
• 2019-2023年區域市場分析
• 2019-2023年國家細分市場分析

第6章 定性分析

• 人工智慧的影響：全球綜合代謝指標檢測市場

第7章五力分析

• 五力分析概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 按應用進行市場細分

• 比較：按應用
• 腎臟疾病
• 糖尿病
• 肝病
• 其他
• 按應用分類的市場機會

第9章 測試法市場區隔

• 比較：通過測試
• 腎功能檢查
• 血糖值
• 肝功能檢查
• 電解質
• 其他
• 測試市場機遇

第10章 按最終用戶進行市場細分

• 比較：按最終用戶
• 檢查機構
• 醫院
• 即時檢測
• 急診室
• 其他
• 按最終用戶分類的市場機會

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 新加坡
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 荷蘭
  • 西班牙
  • 俄羅斯
• 世界其他地區
  • 澳洲
  • 巴西
  • 阿拉伯聯合大公國
  • 南非
  • 沙烏地阿拉伯
  • 土耳其
• 各區域的市場機遇

第13章：促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 令人困惑的局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 企業排名指數
• 公司市場定位
• Abbott Laboratories
• ARUP Laboratories
• Beckman Coulter Inc.
• Bio Rad Laboratories Inc.
• CENTOGENE NV
• F. Hoffmann La Roche Ltd.
• Laboratory Corp.
• Mayo Medical Laboratories
• Quest Diagnostics Inc.
• QuidelOrtho Corp.
• Randox Laboratories Ltd.
• Siemens Healthineers AG
• Sonic Healthcare Ltd.
• SYNLAB International GmbH
• Thermo Fisher Scientific Inc.

第16章附錄

The global comprehensive metabolic panel testing market is forecasted to grow by USD 5839.0 mn during 2024-2029, accelerating at a CAGR of 8.6% during the forecast period. The report on the global comprehensive metabolic panel testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating incidence of chronic diseases, expanding geriatric population, technological advancements in diagnostic and laboratory automation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global comprehensive metabolic panel testing market is segmented as below:

By Application

• Kidney diseases
• Diabetes
• Liver diseases
• Others

By Test

• Kidney function tests
• Glucose
• Liver function tests
• Electrolytes
• Others

By End-User

• Laboratories
• Hospital
• Point-of-care testing
• Emergency departments
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the ascendancy of point-of-care metabolic panel testing as one of the prime reasons driving the global comprehensive metabolic panel testing market growth during the next few years. Also, integration of artificial intelligence in metabolic panel analysis and expansion of at-home and direct-to-consumer metabolic panel testing will lead to sizable demand in the market.

The report on the global comprehensive metabolic panel testing market covers the following areas:

• Global comprehensive metabolic panel testing market sizing
• Global comprehensive metabolic panel testing market forecast
• Global comprehensive metabolic panel testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global comprehensive metabolic panel testing market vendors that include Abbott Laboratories, ARUP Laboratories, Beckman Coulter Inc., Bio Rad Laboratories Inc., CENTOGENE NV, DiaSorin Spa, F. Hoffmann La Roche Ltd., Laboratory Corp., Mayo Medical Laboratories, Metropolis Healthcare Ltd., Quest Diagnostics Inc., QuidelOrtho Corp., Randox Laboratories Ltd., Siemens Healthineers AG, Sonic Healthcare Ltd., SYNLAB International GmbH, Thermo Fisher Scientific Inc., Unipath Specialty Laboratory Ltd.. Also, the global comprehensive metabolic panel testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Test
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Comprehensive Metabolic Panel Testing Market 2019 - 2023
  • Historic Market Size - Data Table on Global Comprehensive Metabolic Panel Testing Market 2019 - 2023 ($ million)
• 5.2 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.3 Test segment analysis 2019 - 2023
  • Historic Market Size - Test Segment 2019 - 2023 ($ million)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global comprehensive metabolic panel testing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Kidney diseases - Market size and forecast 2024-2029
• 8.4 Diabetes - Market size and forecast 2024-2029
• 8.5 Liver diseases - Market size and forecast 2024-2029
• 8.6 Others - Market size and forecast 2024-2029
• 8.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Test

• 9.1 Market segments
• 9.2 Comparison by Test
• 9.3 Kidney function tests - Market size and forecast 2024-2029
• 9.4 Glucose - Market size and forecast 2024-2029
• 9.5 Liver function tests - Market size and forecast 2024-2029
• 9.6 Electrolytes - Market size and forecast 2024-2029
• 9.7 Others - Market size and forecast 2024-2029
• 9.8 Market opportunity by Test
  • Market opportunity by Test ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Laboratories - Market size and forecast 2024-2029
• 10.4 Hospital - Market size and forecast 2024-2029
• 10.5 Point-of-care testing - Market size and forecast 2024-2029
• 10.6 Emergency departments - Market size and forecast 2024-2029
• 10.7 Others - Market size and forecast 2024-2029
• 10.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Asia - Market size and forecast 2024-2029
  • 12.4.1 China - Market size and forecast 2024-2029
  • 12.4.2 India - Market size and forecast 2024-2029
  • 12.4.3 Japan - Market size and forecast 2024-2029
  • 12.4.4 South Korea - Market size and forecast 2024-2029
  • 12.4.5 Indonesia - Market size and forecast 2024-2029
  • 12.4.6 Thailand - Market size and forecast 2024-2029
  • 12.4.7 Singapore - Market size and forecast 2024-2029
• 12.5 Europe - Market size and forecast 2024-2029
  • 12.5.1 Germany - Market size and forecast 2024-2029
  • 12.5.2 UK - Market size and forecast 2024-2029
  • 12.5.3 France - Market size and forecast 2024-2029
  • 12.5.4 Italy - Market size and forecast 2024-2029
  • 12.5.5 The Netherlands - Market size and forecast 2024-2029
  • 12.5.6 Spain - Market size and forecast 2024-2029
  • 12.5.7 Russia - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Australia - Market size and forecast 2024-2029
  • 12.6.2 Brazil - Market size and forecast 2024-2029
  • 12.6.3 UAE - Market size and forecast 2024-2029
  • 12.6.4 South Africa - Market size and forecast 2024-2029
  • 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.6 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating incidence of chronic diseases
  • Expanding geriatric population
  • Technological advancements in diagnostic and laboratory automation
• 13.2 Market challenges
  • Stringent regulatory frameworks and compliance burdens
  • Complex reimbursement policies and increasing pricing pressures
  • Navigating shift towards point-of-care testing and associated data privacy concerns
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Ascendancy of point-of-care metabolic panel testing
  • Integration of artificial intelligence in metabolic panel analysis
  • Expansion of at-home and direct-to-consumer metabolic panel testing

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 ARUP Laboratories
  • ARUP Laboratories - Overview
  • ARUP Laboratories - Product / Service
  • ARUP Laboratories - Key offerings
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 CENTOGENE NV
  • CENTOGENE NV - Overview
  • CENTOGENE NV - Product / Service
  • CENTOGENE NV - Key offerings
  • SWOT
• 15.9 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.10 Laboratory Corp.
  • Laboratory Corp. - Overview
  • Laboratory Corp. - Business segments
  • Laboratory Corp. - Key news
  • Laboratory Corp. - Key offerings
  • Laboratory Corp. - Segment focus
  • SWOT
• 15.11 Mayo Medical Laboratories
  • Mayo Medical Laboratories - Overview
  • Mayo Medical Laboratories - Product / Service
  • Mayo Medical Laboratories - Key offerings
  • SWOT
• 15.12 Quest Diagnostics Inc.
  • Quest Diagnostics Inc. - Overview
  • Quest Diagnostics Inc. - Business segments
  • Quest Diagnostics Inc. - Key offerings
  • Quest Diagnostics Inc. - Segment focus
  • SWOT
• 15.13 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.14 Randox Laboratories Ltd.
  • Randox Laboratories Ltd. - Overview
  • Randox Laboratories Ltd. - Product / Service
  • Randox Laboratories Ltd. - Key news
  • Randox Laboratories Ltd. - Key offerings
  • SWOT
• 15.15 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key news
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.16 Sonic Healthcare Ltd.
  • Sonic Healthcare Ltd. - Overview
  • Sonic Healthcare Ltd. - Business segments
  • Sonic Healthcare Ltd. - Key offerings
  • Sonic Healthcare Ltd. - Segment focus
  • SWOT
• 15.17 SYNLAB International GmbH
  • SYNLAB International GmbH - Overview
  • SYNLAB International GmbH - Product / Service
  • SYNLAB International GmbH - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations